| Autor: |
Nidhi Garg, Renee Pekmezaris, Gerin Stevens, Adan Z. Becerra, Andrzej Kozikowski, Vidhi Patel, Ghania Haddad, Phillip Levy, Pridha Kumar, Lance Becker |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Western Journal of Emergency Medicine, Vol 22, Iss 3 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
1936-9018 |
| DOI: |
10.5811/westjem.2021.1.48978 |
| Popis: |
Introduction: The purpose of this study was to validate and assess the performance of the Emergency Heart Failure Mortality Risk Grade (EHMRG) to predict seven-day mortality in US patients presenting to the emergency department (ED) with acute congestive heart failure (CHF) exacerbation. Methods: We performed a retrospective chart review on patients presenting to the ED with acute CHF exacerbation between January 2014–January 2016 across eight EDs in New York. We identified patients using codes from the International Classification of Diseases, 9th and 10 Revisions, or who were diagnosed with CHF in the ED. Inclusion criteria were patients ≥ 18 years of age who presented to the ED for acute CHF. Exclusion criteria included the following: end-stage renal disease related heart failure; < 18 years of age; pregnancy; palliative care; renal failure; and “do not resuscitate” directive. The primary outcome was seven-day mortality. We used mixed-effects logistic regression models to estimate C-statistics and continuous net reclassification index for events and nonevents. Results: We identified 3,320 ED visits associated with suspected CHF among 2,495 unique patients. Of the 3,320 ED visits, 94.7% patients were admitted to the hospital and 3.4% were discharged. The median age was 78.6 (interquartile range 68.01 – 86.76). There was an overall seven-day mortality of 2%, an inpatient mortality rate of 2.4%, and no mortality among the discharge group. Adding EHMRG to the risk prediction model improved the C-statistic (from 0.748 to 0.772) and led to a higher degree of reclassification for both events and nonevents. Conclusion: The EHMRG can be used as a valuable and effective screening tool in the US while considering disposition decision for patients with acute CHF exacerbation. Emergency medical services transport and metolazone use is much higher in the US population as compared to the Canadian population. We observed minimal to no short-term mortality among discharged CHF patients from the ED. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
